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Abstract 
Introduction: While the current tools to assess canine postoperative pain using physiological and behavioural parameters are 
reliable, an objective method such as the parasympathetic tone activity (PTA) index could improve postoperative care. The aim of 
the study was to determine the utility of the PTA index in assessing postoperative analgaesia. Material and Methods: Thirty 
healthy bitches of different breeds were randomly allocated into three groups for analgaesic treatment: the paracetamol group 
(GPARAC, n = 10) received 15 mg/kg b.w., the carprofen group (GCARP, n = 10) 4 mg/kg b.w., and the meloxicam group (GMELOX,  
n = 10) 0.2 mg/kg b.w. for 48 h after surgery. GPARAC was medicated orally every 8 h, while GCARP and GMELOX were medicated 
intravenously every 24 h. The PTA index was used to measure the analgaesia–nociception balance 1 h before surgery (baseline), 
and at 1, 2, 4, 6, 8, 12, 16, 20, 24, 36, and 48 h after, at which times evaluation on the University of Melbourne Pain Scale (UMPS) 
was made. Results: The baseline PTA index was 65 ± 8 for GPARAC, 65 ± 7 for GCARP, and 62 ± 5 for GMELOX. Postoperatively,  
it was 65 ± 9 for GPARAC, 63 ± 8 for GCARP, and 65 ± 8 for GMELOX. No statistically significant difference existed between baseline 
values or between values directly after treatments (P = 0.99 and P = 0.97, respectively). The PTA index showed a sensitivity of 
40%, specificity of 98.46% and a negative predictive value of 99.07%. Conclusion: Our findings suggest that the PTA index 
measures comfort and postoperative analgaesia objectively, since it showed a clinical relationship with the UMPS. 
 




The state of general anaesthesia is one in which 
various behavioural end points can be distinguished, 
including amnaesia, hypnosis (defined as lack of perceptive 
awareness to non-noxious stimuli), analgaesia, immobility, 
and blunting of autonomic reflexes produced by general 
anaesthetics acting on the neuronal loci (20). When  
a subject is put into this state, a volatile anaesthetic  
acts on the central nervous system to produce two 
irreversible conditions: immobility and amnaesia. These 
drugs may produce some other reversible and clinically 
useful conditions, like unconsciousness, relaxation, 
suppression of autonomic reflexes, or analgaesia, but 
none of these are essential to the definition of the 
anaesthetic state since they are merely side effects (10).  
© 2021 I. Hernández-Avalos et al. This is an open access article distributed under the Creative Commons 
Attribution-NonCommercial-NoDerivs license (http://creativecommons.org/licenses/by-nc-nd/3.0/) 
2 I. Hernández-Avalos et al./J Vet Res/65 (2021) 000-000 
 
The hypnogenic centre in the preoptic area of the 
hypothalamus is responsible for the sleep-promoting 
neurons. The state of rapid eye movement (REM)  
sleep is characterised by a high-frequency, low-
amplitude rhythm on the electroencephalogram (EEG) 
but minimal or absent electromyogram (EMG) activity. 
The effect of amnaesia is produced by abolishing 
hippocampal neurons and basolateral nucleus of the 
amygdala. While consciousness is modulated by 
thalamus, midbrain reticular formation and 
thalamocortical system. To do this, tools such as BIS 
(Bispectral Index) allow assessing the consciousness 
and depth of anaesthesia (20). 
Analgaesia is difficult to measure precisely during 
general anaesthesia, but haemodynamic reactivity, such 
as increased heart rate and blood pressure, may suggest 
failure in achieving it in an anaesthetised patient. 
However, these parameters do not show adequate 
specificity for an independent measurement of the 
intensity or magnitude of pain during the perioperative 
period (14, 30, 35). The analgaesic component of 
anaesthesia can be indirectly monitored for variations in 
sympathetic and parasympathetic tone as an objective 
way of evaluating the balance between nociception and 
antinociception (3, 12). 
Several methods have been implemented to quantify 
the nociception–antinociception balance in the anaesthetised 
patient in a more reliable way, e.g. the analysis of reflex 
pathways, pulse photoplethysmography, skin vasomotor 
reflexes via laser Doppler flowmetry, pupillometry, 
cerebral evoked potentials, and heart rate variability 
(HRV) (1, 5, 7, 11, 12). In human anaesthesiology, the 
analgaesia–nociception index (ANI), a recent development 
derived from HRV, has been validated for intraoperative 
nociception detection (3, 5, 8, 15, 24), as it reflects the 
relative parasympathetic tone (11). This technology was 
adapted for the study of acute pain in dogs, cats, and 
horses in the form of a parasympathetic tone activity 
(PTA) monitor, using an algorithm similar to that of the 
ANI. Both indices assess intraoperative nociception 
based on the analysis of HRV to measure relative 
parasympathetic tone, sympathetic balance (26), and 
analgaesia–nociception balance during a painful stimulus 
(23, 26, 27). 
PTA index values range from 0 to 100. An index of 
50–70 suggests the absence of nociception; values close 
to 100 correspond to a predominant parasympathetic 
tone (low level of stress) or opioid overdose; and values 
below 50 correspond to a predominant sympathetic tone 
(anticipating haemodynamic responses) associated with 
a high level of stress or nociceptive pain in dogs 
undergoing surgical procedures. The PTA index can also 
be used to predict immediate postoperative analgaesia 
(4, 6). 
The ANI index has been validated for use in human 
medicine as a non-invasive tool to assess pain during the 
immediate postoperative period, as it correlates 
significantly with pain intensity (6). It has been 
evaluated during general anaesthesia in adults and 
children as an intraoperative tool (17) and for labour 
pain evaluation, and exhibited significant changes 
between periods with and without pain (22). However, 
equivalent studies in animal medicine using the PTA 
index have not been undertaken. 
The objective of this study was to rectify this 
deficiency in knowledge by determining the utility of the 
PTA index for assessment of analgaesia during the 
postoperative period in female dogs undergoing 
ovariohysterectomy. We hypothesised that the PTA 
index could be used to assess pain response, as its dynamic 
variation can be used as a signal of a haemodynamic 
response associated with pain. 
Material and Methods 
This was a randomised, prospective, blinded 
clinical study. 
Animals. For the present study, we selected 30 
bitches of different breeds which were scheduled for 
elective ovariohysterectomy. We obtained prior written 
informed consent from the owners for their animals’ 
participation in the study. The patients had a weight of 
11.2 ± 6.2 kg (mean ± standard deviation), and an age of 
2.7 ± 1.7 years. All dogs were clinically healthy as 
determined by physical examination, complete blood 
count, urinalysis, and serum biochemical analysis. 
Brachycephalic breeds and patients prescribed 
antiarrhythmic treatment were excluded. 
Experimental design and anaesthetic and 
surgical procedure. Animals were received 48 h prior 
to the surgical procedure and had access to commercial 
feed and water ad libitum in that time. All animals were 
fasted for 8 h before surgery. On the day of the surgery, 
the animals were randomly assigned to one of three 
treatment groups: the GPARAC group administered 
paracetamol/acetaminophen (15 mg/kg b.w., intravenously 
(IV); Tempra (Reckitt Benckiser S.A. De C.V., Ciudad 
de México, Mexico); the GCARP group treated with 
carprofen (4 mg/kg b.w., IV; Rimadyl, Zoetis Inc., 
Kalamazoo, MI, USA); and the GMELOX group receiving 
meloxicam (0.2 mg/kg b.w., IV; Meloxi-Jet NRV, 
NorVet, Torreón, Mexico). A venous catheter was 
inserted and the selected analgaesic was administered  
30 min before surgery. An isotonic fluid solution (0.9% 
sodium chloride solution, PiSA Farmacéutica, Ciudad 
de México, Mexico) was administered at a flow rate of 
10 mL/kg b.w./h. Anaesthesia was induced by 
administration of propofol (2–6 mg/kg b.w. IV; Recofol, 
PiSA Farmacéutica) to allow intubation, and maintained 
with an initial end-tidal isoflurane concentration of  
1.3% (Forane, Baxter International Inc., Deerfield, IL, 
USA). 
During surgery, this concentration was increased 
or decreased based on the depth of anaesthesia required 
for surgery based on clinical signs, including absence 
of the palpebral reflex, relaxed jaw tone, and mean 
arterial pressure of 60–90 mmHg. Immediately after 
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induction, fentanyl was administered (5 μg/kg b.w. IV; 
Fenodid, PiSA Farmacéutica) and constantly infused  
at 5 μg/kg b.w./h. At the end of surgery, fentanyl 
infusion was discontinued. The dogs were 
mechanically ventilated at an initial respiratory rate 
(RR) of 15 breaths per minute and a tidal volume of 
12–15 mL/kg b.w. adjusted to maintain end-tidal 
carbon dioxide tension (ETCO2) of 35–45 mmHg, 
which was facilitated by administration of rocuronium 
(0.6 mg/kg b.w. IV; Lufcuren, PiSA Farmacéutica). All 
anaesthetic and surgical procedures were performed by 
the same anaesthetist and surgeon. Postoperatively for 
48 h, paracetamol was administered to the designated 
group dogs every 8 h in doses of 15 mg/kg b.w. orally, 
and carprofen (4 mg/kg b.w.) and meloxicam were 
administered to the appropriate subjects every 24 h, IV. 
In this period, the dose of meloxicam was reduced  
to 0.1 mg/kg b.w. 
During anaesthesia, heart rate (HR), ETCO2 and 
pulse oximetry were monitored. A 22-gauge catheter 
was aseptically placed in the dorsal metatarsal artery 
and attached to a transducer (DTX plus DT 4812; 
Becton Dickinson Critical Care Systems Pte. Ltd., 
Singapore) for direct monitoring of arterial blood 
pressure (systolic blood pressure (SBP), diastolic and 
mean). Thermal support was provided throughout the 
surgery to maintain the temperature in physiological 
ranges (36–38°C) (Equator Convective Warming 
Device, Smiths Medical, Inc., Minneapolis, MN, 
USA). Neuromuscular function was monitored via 
acceleromyography (Stimpod, Xavant Technology Pty, 
Pretoria, South Africa), stimulating the ulnar nerve in 
a train-of-four pattern and calculating the train-of-four 
ratio T4 : T1. The dogs were extubated only after T4 : T1 
was > 0.90. 
Evaluation of postoperative analgaesia using the 
PTA index. Analgaesia assessments were completed by 
the same investigator, using a Physio Doloris PTA 
monitor (MDoloris Medical Systems, Loos, France), and 
the investigator was blinded to the treatment group. The 
baseline assessment was performed 60 min before 
surgery in a quiet and calm environment. Further 
assessments were performed postoperatively at 1, 2, 4, 
6, 8, 12, 16, 20, 24, 36, and 48 h, likewise in a stress-free 
environment. 
The PTA monitor displays a graphic recording of 
the derivative II of the electrocardiogram (ECG), via 
three electrodes attached to the skin with conductive gel. 
The red and yellow electrodes were placed on the right 
and left forelimbs, respectively, at the level of the 
olecranon on the caudal aspect of the limb. The black 
electrode was placed on the right hindlimb, over the 
patellar ligament at the cranial face of the pelvic limb 
(28). The device’s algorithm was used to calculate the 
PTA index. 
The PTA index was calculated according to the 
following formula: 
PTA = (100*[α *AUCmin + β] / 12.8)*100/161 
where α and β values have been empirically determined 
as 5.1 and 1.2, respectively, to maintain the consistency 
of the respiratory influence on the R–R interval series of 
the ECG; AUCmin is the minimum area under the curve; 
and 100/12.8 and 100/161 are coefficients for different 
species determined to obtain PTA values between 0 and 
100, with 100/161 being specific to the dog (7, 28). 
HRV was evaluated via the PTA monitor as a non-
invasive method to measure the activity of the 
autonomic nervous system. HRV was based on two main 
components of the ECG: low frequency variations 
(0.004–0.15 Hz) as an indicator of sympathetic activity, 
and high frequency variations (0.15–0.5 Hz) as an indicator 
of parasympathetic activity. The latter are mainly influenced 
by respiratory sinus arrhythmia (30). 
The PTA monitor continuously shows the 
instantaneous/immediate PTA index, as well as the 
average/mediate PTA index values collected over 120 s 
and 240 s. The PTA index was continuously measured 
through a window of 64 s after each measurement (4, 6, 
22, 27, 28). The PTA monitor was calibrated with the 
canine-specific coefficients already described. Once the 
ECG electrodes were placed, the criteria for considering 
a PTA index measurement valid was the monitor 
recording good signal quality. For each postoperative 
analgaesia assessment interval, HRV was recorded for  
5 min with the patient standing, at which time the 
average/mediate PTA index value was recorded. At the 
same postoperative examination times, the validated 
University of Melbourne Pain Scale (UMPS) score was 
evaluated (34). 
Rescue analgaesic medication. When dogs 
showed a PTA < 50 and a score > 10 on the UMPS scale, 
rescue analgaesia was administered. For this, tramadol 
was used (2 mg/kg b.w. IV; Tramadol Jet NRV 
injectable solution; NorVet, Torreón, Mexico). Animals 
which received rescue analgaesia were reported but not 
included in the study. The same investigator performed 
all the measurements. 
Statistical analysis. Statistical analyses were 
performed using Prism version 8.3.1 (GraphPad 
Software, LLC, San Diego, CA, USA). The Shapiro–
Wilk test was used for the assessment of data normality. 
Data were reported as the mean value ± standard 
deviation. The PTA index data were analysed via  
a repeated measures ANOVA test, followed by a Holm–
Šídák post-hoc test to account for multiple comparisons. 
The Friedman non-parametric ANOVA and Dunn’s 
tests were used to analyse postoperative pain as 
measured by UMPS. Sensitivity, specificity and 
negative predictive value for the PTA index were 
calculated. Values were considered statistically different 
when P < 0.05. 
In this study, we estimated that nine dogs for any 
group were sufficient to assert that a difference of 20 
PTA index scores (65 ± 15 versus 45 ± 15) indicated 
absence or presence of nociception with a power of 0.8 
(Type II error) and alpha level of 0.05 (Type I error). 
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Results  
Fig. 1 depicts the PTA indices measured for the 
three study groups. It should be noted that the mean PTA 
indices measured for all three study groups and at all 
assessment intervals were similar. The baseline PTA 
index for GPARAC was 65 ± 8, for GCARP it was 65 ± 7, and 
for GMELOX it was 62 ± 5. During the postoperative 
period, the PTA index was 65 ± 9 for GPARAC, 63 ± 8 for 
GCARP, and 65 ± 8 for GMELOX (Fig. 1). We detected no 
statistically significant difference between either 
baseline values or between treatments (P = 0.99 and  
P = 0.97), respectively. 
For 26 dogs, postoperative PTA indices were 
within normal parameters. Four dogs (one dog in GPARAC 
and GMELOX and two dogs in GCARP) required rescue 
analgaesia as subjects with PTA indices between 40 and 
49 (moderate pain) and a score > 10 in UMPS. The 
scores on this scale for the three study groups during the 
postoperative period are listed in Table 1. These results 
were used in this investigation as a reference for the 
evaluation and validation of the clinical utility of the 
PTA index in conscious animals. The sensitivity, 
specificity and negative predictive value are presented in 
Table 2, which shows that PTA index has a greater 
capacity to recognize pain-free states associated with 
comfort and postoperative analgaesia. Therefore, with 
the determination of these diagnostic characteristics, it 
was possible to establish that individuals who 
manifested pain could be recognised through the 
measurement of PTA index and by clinical observation 
performed by UMPS. 
 
 
Fig. 1. Postoperative PTA values during different treatment times with carprofen, meloxicam, and 
paracetamol  
The P value comparing the PTA indices between treatments was 0.97 and the P value 
comparing baseline values to post-operative values was 0.99 
 
 
Table 1. UMPS scores during the postoperative period in GPARAC, GCARP, and GMELOX 
Postoperative period (hours) 
 1 2 4 6 8 12 16 20 24 36 48 
GPARAC 5.5±0.8 4.5±0.8 3.0±0.6 3.0±0.4 2.0±0.4 2.0±0.4 1.5±0.3 1.0±0.3 1.0±0.3 0.0±0.2* 0.0±0.2* 
GCARP 4.5±1.4 4.0±0.6 3.0±0.3 2.0±0.3 2.0±0.3 1.0±0.4 1.0±0.4 0.5±0.4 0.0±0.4* 0.0±0.1* 0.0±0.1* 
GMELOX 5±0.9 3.5±0.8 3.0±0.4 2.5±0.3 1.5±0.5 0.5±0.3 0.5±0.3 0.0±0.1* 0.0±0.1* 0.0±0.0* 0.0±0.0* 
(*) Statistically significant differences from the first evaluation (P = 0.001) 
No statistically significant differences were found between treatments (P = 0.99) 
 
Table 2. Intrinsic diagnostic characteristics of the PTA index  





Negative predictive value 99.07% 
 






















The process of pain assessment during the 
postoperative period is affected by factors in the assessor 
such as their age and sex, pharmacological knowledge 
of analgaesic medication, attitude toward pain, clinical 
experience of its identification and ability to quantify 
and manage it. Therefore, observations of pain should be 
made consistently by the same person (14, 31). These 
human factors have led to tools that evaluate the 
sympathetic–parasympathetic tone balance attracting 
special interest (18, 32), as one of the first responses of 
an organism to surgical stress is an increase in 
sympathetic tone and a decrease in parasympathetic 
tone, which influences HRV (23, 29). 
In the case of a predominant parasympathetic tone, 
each inhalation briefly increases HR and concomitantly 
decreases the R–R interval of the ECG, which can cause 
a wide variation in the R–R pattern. Conversely, in the 
case of a predominant sympathetic tone, the HR 
increases, but the effect of respiratory arrhythmia on the 
R–R pattern diminishes, which results in a filtered band 
with little variation that allows the evaluation of the 
analgaesia–nociception balance (7, 16, 17). Thus, in the 
present study, the PTA index calculated for the GPARAC, 
GCARP, and GMELOX groups indicated that patients 
exhibited postoperative analgaesia. 
Mansour et al. (28) reported the measurement of 
the PTA index, as well as HR, SBP, and haemodynamic 
response (defined as a > 20% increase in HR and/or SBP 
within 5 min of a stimulus) after various surgical stimuli. 
The authors detected a significant decrease in PTA  
(P < 0.002) 1 min after the stimuli, followed by  
a significant increase in HR and/or SBP within 5 min  
(P < 0.01). Therefore, they concluded that in the 
veterinary clinical context, the PTA index is a measure 
of the analgaesia–nociception balance, and can signal  
a haemodynamic response in anaesthetised dogs. Based 
on these results, the PTA index could be used to detect 
perioperative nociception and optimise the administration 
of analgaesics during or after canine surgery. This 
corresponded with the present study, where the PTA 
index ranged from 62 to 65 during the postoperative 
period in the three study groups, indicating the 
analgesia–nociception balance. 
The PTA index during the intraoperative period has 
also been evaluated in male dogs subjected to castration 
and females undergoing ovariohysterectomy, where  
a significant difference was observed and the PTA values 
were higher (indicative of a lower degree of nociception) 
in males (61 ± 19) than in females (50 ± 17), as well as 
in patients where an epidural block was used (57 ± 19 
versus 48 ± 18; P = 0.003) (33). In that same study,  
a statistically null correlation was  reported between the 
PTA index values and mean arterial pressure (P = 0.045). 
Thus, the authors concluded that the PTA monitor can 
be useful to evaluate the degree of intraoperative 
nociception. In the present study, a monitor of this type 
was used to measure postoperative nociception under the 
same precept, where the treatments used provided  
an adequate level of analgaesia. 
Recently, Aguado et al. (1) applied electrical 
nociceptive stimuli of different intensities to research 
dogs and demonstrated that at low intensity, the PTA 
monitor was able to detect nociceptive responses before 
cardiovascular changes in HR and mean arterial pressure 
were elicited. In our study, the PTA values were not 
significantly different between baselines or between 
treatments and HR and HRV ranges measured in the 
PTA monitor were within normal ranges. These authors 
also demonstrated that changes in the cardiovascular 
constants were only detected with high intensity 
nociceptive electrical stimulation, along with low values 
for the PTA (between 0 and 39). 
Given that the studies or reports carried out so far 
in dogs are scarce, articles related to the postoperative 
period in humans where the ANI has been used as a tool 
to measure patients’ pain will be used in the discussion. 
In a prospective observational study of 200 individuals 
undergoing orthopaedic surgery, Boselli et al. (4) 
assessed the ANI upon patients’ awakening from general 
anaesthesia to predict immediate postoperative pain 
upon reaching the recovery room (post-anaesthesia care 
unit), reporting a negative correlation between the ANI 
measured immediately before extubation and the simple 
numerical scale upon arrival at the care unit. This same 
behaviour was observed by Boselli et al. (6) in another 
study in which they concluded that the ANI monitor is  
a useful tool during the immediate postoperative period 
in human patients undergoing scheduled surgery or 
endoscopy under general anaesthesia, where this index 
is significantly correlated with pain intensity. Thus, with 
the results obtained it can be inferred that the 
measurement of the ANI or the PTA is a simple and non-
invasive method to evaluate immediate postoperative 
analgaesia. 
This usefulness is consistent with that described by 
Ledowski et al. (25), who mentioned that the ANI index 
based on HRV is a parameter proposed in postoperative 
monitoring to reflect different levels of acute pain, 
presenting a situation similar to what was observed in 
the present study. However, unlike our research, these 
authors reported a statistically significant negative 
correlation between the ANI index scores and the 
numerical rating scale (0–10) based on the assessment of 
pain in the recovery room after general anaesthesia with 
sevoflurane in adult patients. 
In the present study, four analgaesic rescues were 
performed where the values in the PTA index resolved 
to moderate pain. These patients also presented a score 
> 10 in UMPS. In this regard, the ability of the PTA 
index to detect pain in patients who manifest it clinically 
(the index’s sensitivity) has been reported by other 
researchers (3, 28) where it fluctuated between 77% and 
86%; specificity ranged from 72% to 86%, and the 
negative predictive value was 92% (3). These results 
were similar to those calculated in the present study. 
Therefore, the PTA index appears to be a reliable tool to 
measure the degree of analgaesia. 
In human medicine, there are more studies where 
the activity of the parasympathetic tone is evaluated 
through the capacity of the ANI monitor to detect 
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nociceptive stimulation (16, 17), but there are questions 
regarding the use of a similar index in animals due to 
species variations of the sympathovagal balance. 
Nevertheless, HRV measurements that were described 
in dogs had similar values to those reported in humans, 
with a low frequency of 0.004–0.15 Hz and a high 
frequency of 0.15–0.5 Hz (30), which allows 
comparison of the results obtained in this study with 
those cited by various researchers in human studies. 
In practice, there are factors external to nociception 
that can influence the reading of the PTA index, such as 
age, species, the increased vagal tone in brachycephalic 
breeds, arrhythmia, apnoea, fewer than 8 respiratory 
cycles/min, the operation of a pacemaker, pathologies 
(e.g. epilepsy or cerebrovascular accident) or 
medications (e.g. atropine or vasopressors such as 
dobutamine and sedatives such as medetomidine or 
dexmedetomidine) that interrupt the regulation of the 
autonomic nervous system (3, 5, 9, 13, 37). However, at 
least in humans, there is evidence that intravenous 
ketamine microdose infusion contributes to analgaesia 
without affecting the ANI index under clinical 
conditions (2). The PTA index therefore helps to assess 
whether there is an analgaesic sub or overdose condition 
during the perioperative period (24, 26). 
The PTA index as applied in this study could also 
have been misrepresentative during the first minutes of 
postoperative evaluation after extubation, since the 
evaluation of nociception with this type of tool that 
assesses the autonomous cardiovascular control of HRV 
in real time has previously aggregated data related to 
negative emotional states (including pain, stress, anxiety 
and aggressiveness) in dogs (19, 21, 38). The dogs in this 
study were assessed by the anaesthetist during recovery 
and deemed to be calm and comfortable, which should 
have minimised autonomic responses that affect the 
PTA index; this was also evidenced by the low number 
of dogs that exhibited a PTA index indicative of pain. 
This study offers some significant benefits for pain 
assessment in conscious patients or in the postoperative 
period, however, this research has some limitations that 
require discussion. For example, the dogs included in 
this study have a potentially different variability of 
nervous system activity due to size, age and breed, so 
future studies should consider a homologation of these 
factors. Additional studies are needed to validate the use 
of the PTA index to rate postoperative pain when 
considering other forms of nociceptive stimuli, since the 
present study only examined healthy dogs after elective 
surgery. Also, it is recommended that in future 
investigations, the use of this device should be 
considered against other analgaesic options, such as the 
new opioid agonist related to the selective activation of 
the β-arrestin signalling pathway called oliceridine (36), 
a drug that has recently been approved for perioperative 
pain control as an alternative to morphine or fentanyl, 
and opioids that influence HRV and have shown 
properties that can modify the PTA index values. 
Likewise, the PTA monitor also has some limitations in 
conscious patients, since the electrocardiogram signal 
can be altered by the animal’s movements (28). Finally, 
the PTA monitor does not show the dynamic value of the 
HRV, and consequently it must be calculated based on 
the static values provided by the same monitor. In this 
study, this restricted PTA reporting to only the 
median/average values. 
In conclusion, our findings suggest that the PTA 
index represents an objective measurement of comfort 
and analgaesia during the postoperative period, since it 
showed a clinical relationship with the UMPS; therefore, 
it is a tool that could help monitor the haemodynamic 
responses associated with pain or stress. 
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